$1.21
+0.00 (+0.00%)
Open$1.24
Previous Close$1.21
Day High$1.24
Day Low$1.20
52W High$2.89
52W Low$1.17
Volume—
Avg Volume2.29M
Market Cap305.41M
P/E Ratio—
EPS$-0.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,234.7% upside
Current
$1.21
$1.21
Target
$16.15
$16.15
$10.52
$16.15 avg
$19.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 925.69M | 842.00M | 59.12M |
| Net Income | -15,421,893 | -12,624,798 | 16.50M |
| Profit Margin | -1.7% | -1.6% | 27.9% |
| EBITDA | 42.98M | 37.14M | 25.74M |
| Free Cash Flow | — | — | 14.78M |
| Rev Growth | +9.9% | +9.9% | +13.8% |
| Debt/Equity | 0.15 | 0.15 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |